Eur Heart J:房间隔缺损患者的长期死亡率分析!

2017-12-04 xing.T MedSci原创

总的来说,ASD患者的长期死亡率比出生年份和性别匹配的一般人群要高。该研究的数据表明接受封堵的ASD患者相对死亡率比未进行封闭的ASD患者死亡率要低。

近日,心血管领域权威杂志Eur Heart J上发表了一篇研究文章,这个全国范围内的房间隔缺损(ASD)患者队列是迄今为止规模最大的一个队列,研究人员旨在报告与一般人群相比,在儿童期和成年期封闭和不封闭的ASD患者最长随访时间后的结果。

研究人员利用以人群为基础的注册中心,纳入了1994年以前出生的丹麦人,这些受试者在1959年到2013年期间被诊断为ASD。研究人员对受试者的所有诊断进行了验证(n=2277),并采用Kaplan-Meier估计和Cox比例风险回归进行分析,在调整性别、出生年份和改良的Charlson合并症指数后。研究人员比较了ASD患者与出生年份和性别相匹配的一般人群队列的死亡率。

从ASD诊断开始中位随访时间为18.1年(范围为1-53 年)。与普通人群相比,ASD患者有更高的死亡率[调整后的风险比(HR)为1.7,95%可信区间(CI)为1.5-1.9)。封闭后30 天调整后的HR为1.4(95%CI为1.2-1.7),而未进行封闭的患者HR为2.4(95%CI为2-2.9)。

总的来说,ASD患者的长期死亡率比出生年份和性别匹配的一般人群要高。该研究的数据表明接受封堵的ASD患者相对死亡率比未进行封闭的ASD患者死亡率要低。

原始出处:


Camilla Nyboe,et al. Long-term mortality in patients with atrial septal defect: a nationwide cohort-study. Eur Heart J.2017. https://doi.org/10.1093/eurheartj/ehx687

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1356589, encodeId=f0c2135658910, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459424, encodeId=140114594240c, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562758, encodeId=36b61562e58dc, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266981, encodeId=19c82669811f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Dec 05 12:44:32 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266880, encodeId=d0b226688009, content=学习了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 05 06:44:18 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266787, encodeId=88da266e877a, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 04 19:49:00 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2017-12-06 zhaojie88
  2. [GetPortalCommentsPageByObjectIdResponse(id=1356589, encodeId=f0c2135658910, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459424, encodeId=140114594240c, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562758, encodeId=36b61562e58dc, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266981, encodeId=19c82669811f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Dec 05 12:44:32 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266880, encodeId=d0b226688009, content=学习了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 05 06:44:18 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266787, encodeId=88da266e877a, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 04 19:49:00 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1356589, encodeId=f0c2135658910, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459424, encodeId=140114594240c, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562758, encodeId=36b61562e58dc, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266981, encodeId=19c82669811f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Dec 05 12:44:32 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266880, encodeId=d0b226688009, content=学习了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 05 06:44:18 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266787, encodeId=88da266e877a, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 04 19:49:00 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2017-12-06 slcumt
  4. [GetPortalCommentsPageByObjectIdResponse(id=1356589, encodeId=f0c2135658910, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459424, encodeId=140114594240c, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562758, encodeId=36b61562e58dc, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266981, encodeId=19c82669811f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Dec 05 12:44:32 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266880, encodeId=d0b226688009, content=学习了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 05 06:44:18 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266787, encodeId=88da266e877a, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 04 19:49:00 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2017-12-05 sunfeifeiyang

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1356589, encodeId=f0c2135658910, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459424, encodeId=140114594240c, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562758, encodeId=36b61562e58dc, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266981, encodeId=19c82669811f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Dec 05 12:44:32 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266880, encodeId=d0b226688009, content=学习了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 05 06:44:18 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266787, encodeId=88da266e877a, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 04 19:49:00 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2017-12-05 1209e435m98(暂无昵称)

    学习了.谢谢分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1356589, encodeId=f0c2135658910, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459424, encodeId=140114594240c, content=<a href='/topic/show?id=0820542427d' target=_blank style='color:#2F92EE;'>#房间隔缺损#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54242, encryptionId=0820542427d, topicName=房间隔缺损)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562758, encodeId=36b61562e58dc, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Wed Dec 06 09:23:00 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266981, encodeId=19c82669811f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Dec 05 12:44:32 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266880, encodeId=d0b226688009, content=学习了.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Dec 05 06:44:18 CST 2017, time=2017-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266787, encodeId=88da266e877a, content=非常好的文章.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Dec 04 19:49:00 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2017-12-04 天涯183

    非常好的文章.学习了

    0

相关资讯

Nat Commun:接触重金属,可能会导致自闭症

虽然还不知道是什么原因导致自闭症,但研究人员认为,是环境因素与遗传因素之间复杂的相互作用导致了该疾病的发生。但要想把这些因素分离开则是一个不小的挑战。一项最新研究发现了一种能够将导致自闭症的遗传因素与环境因素相分离的方法,使研究者能够专注于研究体内重金属水平与自闭症风险之间的关系。

Pediatrics:孕妇或许应谨慎使用β2-肾上腺素能受体激动剂

研究者进行了一项研究,探究宫内β2-肾上腺素能受体(B2AR)激动剂药物的暴露与后代自闭症谱系障碍(ASD)风险。该病例对照试验纳入了5200例ASD和52000例没有ASD的对照组,两组在出生年月上匹配。使用条件逻辑回顾模型评估孕期、受孕前、早中晚孕时孕妇B2AR激动剂的使用与后代ASD的OR和CI。研究数据显示,病例组和对照组孕期暴露B2ARs的比例分别是3.7%和2.9%。孕期使用B2ARs

Sci Rep:在怀孕时吸烟竟能增加隔代子女患自闭症风险!

自闭症和自闭症谱系障碍使儿童缺乏像其他孩子那样能与世界互动的能力,自闭症谱系障碍(ASD)的特征是社会互动困难,沟通存在问题和习惯从事重复行为。虽然自闭症谱系障碍的遗传背景有很多的研究,但环境因素有可能导致患病率随时间的变化。啮齿动物实验表明,环境暴露可以对后代产生影响;人类研究表明,父母产前暴露可能在发育变化中发挥重要作用。

Nat Med:全基因组测序发现自闭症遗传基础复杂

由自闭症研究机构Autism Speaks资助、有史以来规模最大的自闭症基因组研究表明,这种疾病的遗传学基础甚至比我们以前认为的更为复杂:大多数患有自闭症谱系障碍(ASD)的兄弟姐妹,有着不同的自闭症相关基因。这项研究由Autism Speaks MSSNG项目主任带领,以封面文章的形式发表在1月26日的《自然医学》(Nature Medicine)。 同时

Oncotarget:孤独症也是免疫性疾病?

近年来,越来越多的研究表明神经、精神类疾病如精神分裂症、阿兹海默症的发生与免疫系统的异常有关。孤独症是一类以刻板动作,社交障碍为核心症状的儿童神经发育性疾病,然而,在儿童孤独症患者中是否有哪些免疫系统的异常,并无系统性的研究。近日来自于四川大学华西第二医院许文明教授课题组与西南交通大学临床医院谢江教授的一项合作研究,针对孤独症儿童的免疫特性及与孤独症儿童的行为异常的关系进行了系统的研究,为这一问题

J Child Psychol Psychiatry:维生素D补充剂可改善自闭症儿童的症状与体征

自闭症谱系障碍(ASD)是一种常见的发育障碍性疾病,其特征的社会交往能力、语言及非语言交流能力的丧失,兴趣与活动单一刻板。既往研究发现自闭症儿童维生素D缺乏;然而,缺乏关于ASD儿童维生素D补充剂的随机对照试验。本研究旨在探究维生素D补充剂对ASD儿童主要症状的影响。采用随机双盲对照临床试验(RCT)设计,纳入109名ASD儿童(85名男孩和24名女孩;年龄为3-10岁)。将ASD患儿随机分组,分